Clinical Trials Browser

Interventional × Re-Irradiation × 90 days × Clear all

NCT07612254 2026-05-28

REPEAT

Phase 1/2 Not yet recruiting

Breast Cancer Recurrent

NCT01743950 2026-03-25

A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab

Phase 2 Terminated

49 enrolled 19 charts

Glioblastoma, Glioma